In this week's edition of 5 Minutes of Management, Workforce editors Frank Kalman and Rick Bell talk about the record number of job openings in the U.S. and tackle the finger pointing between an industry association, insurance firms and pharmacy benefits managers regarding the soaring cost of making pharmaceuticals such as the EpiPen. Also, why is the figure 20 million so significant?
Tags: BIO, EpiPens, job openings, Mylan, PBMs, pharmaceuticals
The post 5MM: Job Openings Jump; Justifying EpiPen Costs appeared first on Workforce Magazine.
No comments:
Post a Comment